Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.42 USD | +1.23% | +8.12% | -2.62% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.62% | 1.92B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-13.64% | 32.81B | |
+51.46% | 25B | |
-16.76% | 15.29B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+5.47% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Transcript : Catalyst Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 17, 2022